Gamers Make

Long-time period responses in patients with recurring or refractory B-cell non Hodgkin lymphoma handled with yttrium 90 ibritumomab tiuxetan. Topical 2% cyclosporine A in preservative-free artificial tears for the therapy of vernal keratoconjunctivitis. From 2017 onwards, the programme will be expe...